Breaking News

A looming decision on march-in rights; how regulatory warnings change drug prescribing

   

 

Pharmalot Ed Silverman

STAT+: Will a looming decision on march-in rights be a groundbreaking move, or 'one more nail in the coffin'?

By Ed Silverman

Adobe

"If we have this march-in authority, this seems like a pretty good time to use it," says Robert Cook-Deegan of Arizona State University.

Read More

STAT+: Regulatory warnings about drugs are tied to modest drops in prescribing

By Ed Silverman

Adobe

Around 50% of adverse events that send people to emergency departments or hospitals are preventable, said co-author Barbara Mintzes.

Read More

Opinion: What I learned from Paul Farmer: Treat the systems around the patient, not just the disease

By Junaid Nabi

Dieu Nalio Chery/AP

Paul Farmer taught others to work toward treating the systems that surround patients, and not just the diseases they had.

Read More

Scientists take key step toward unraveling the genetic roots of ALS in a pair of studies

By Jonathan Wosen

Adobe

Teams led by scientists at Stanford and University College London made essentially the same discovery on ALS at the same time.

Read More

Wednesday, February 23, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments